Global Stem Cells Group announced that it has signed a memorandum of understanding with the Regenerative Technology Alliance (RTA) to evaluate and promote stem cell training programs.
Global Stem Cells Group and the Regenerative Technology Alliance (RTA) have signed a memorandum of understanding to evaluate and promote stem cell training programs. RTA, a global provider of standards and certification for the emerging fields of regenerative medicine and science, will work with the Global Stem Cells Group to evaluate the regenerative medicine company’s training programs and assess GSCG’s participating physicians against the RTA’s established international standards for the practice of regenerative and cell-based medicine.
“Our new alliance with the RTA is a natural step toward establishing GSCG’s recognition as a global leader in stem cell medicine,” says Global Stem Cells Group CEO Benito Novas. “This is a perfect fit for us, as Global Stem Cells Group shares the RTA’s focus on high standards and transparency, especially when it comes to patient safety and advancing the field of stem cell medicine.”
“We are very pleased to have this alliance,” says David Audley, General Secretary and Chair of the RTA. “Our goal is to provide the highest level of transparency and oversight for the industry. Working with Global will allow us to have a direct and dramatic impact on physician training.”
About the RTA
The Regenerative Technology Alliance (RTA) a global provider of standards and certification for the emerging fields of regenerative medicine and science, is a 501(c)3 and is supported by donations from individuals, corporations and foundations to help advance its critical mission of bringing peer oversight and transparency to the field of cell-based and regenerative medicine.
